financetom
Business
financetom
/
Business
/
Open Text Names James McGourlay Interim CEO, Forms Executive Committee
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Open Text Names James McGourlay Interim CEO, Forms Executive Committee
Aug 11, 2025 5:24 AM

07:58 AM EDT, 08/11/2025 (MT Newswires) -- Open Text ( OTEX ) said Monday it has appointed James McGourlay as interim chief executive officer, effective immediately.

McGourlay, who held the role of executive vice president for international sales, succeeds Mark Barrenechea, who also steps down as the company's chief technology officer and board vice chairman, the company said.

Open Text ( OTEX ) said it appointed P. Thomas Jenkins as executive chair and chief strategy officer and Savinay Berry as chief technical officer. The company said it also established an executive committee to support the leadership team during the transition period, chaired by Jenkins.

The company said it will continue to work with its financial advisors to explore portfolio-shaping opportunities that focus on its core business of information management for AI.

Open Text's ( OTEX ) board has formed a CEO search committee and will retain a leading executive search firm to assist with the process, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Super Hi International Q3 Earnings Fall, Revenue Rises
Super Hi International Q3 Earnings Fall, Revenue Rises
Nov 26, 2025
05:26 AM EST, 11/26/2025 (MT Newswires) -- Super Hi International ( HDL ) reported Q3 earnings Wednesday of $0.01 per diluted share, down from $0.06 a year earlier. Revenue for the quarter ended Sept. 30 was $214 million, up from $198.6 million a year earlier. Two analysts surveyed by FactSet expected $228.4 million. ...
Update: Nutanix Fiscal Q1 Adjusted EPS In-Line But Revenue Misses; Cuts Full-Year Sales Outlook; Shares Sink Premarket
Update: Nutanix Fiscal Q1 Adjusted EPS In-Line But Revenue Misses; Cuts Full-Year Sales Outlook; Shares Sink Premarket
Nov 26, 2025
05:30 AM EST, 11/26/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Nutanix ( NTNX ) shares were down more than 16% in Wednesday's premarket activity after the company reported overnight Q1 sales growth that lagged market expectations, and the outlook for full-year revenue was also scaled back, taking the shine off in-line...
Ascendis Pharma Says FDA Extended Review Period for TransCon CNP in Children With Achondroplasia by Three Months
Ascendis Pharma Says FDA Extended Review Period for TransCon CNP in Children With Achondroplasia by Three Months
Nov 26, 2025
05:27 AM EST, 11/26/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) said late Tuesday that the US Food & Drug Administration has extended the review period for its TransCon CNP drug candidate to treat children with achondroplasia, which causes dwarfism, by three months to Feb. 28, 2026. The FDA notified the company that its submission related to post-marketing requirements...
Pinnacle Financial Partners, Synovus Financial Secure US Federal Reserve Approval for Planned Merger
Pinnacle Financial Partners, Synovus Financial Secure US Federal Reserve Approval for Planned Merger
Nov 26, 2025
05:42 AM EST, 11/26/2025 (MT Newswires) -- Pinnacle Financial Partners ( PNFP ) and Synovus Financial ( SNV ) said late Tuesday their planned merger received regulatory approval from the US Federal Reserve. Shareholders of both companies already approved the merger on Nov. 6 and the transaction is now expected to close on Jan. 1, 2026, the companies said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved